D
Teva Pharmaceutical Industries Limited TEVA
$16.33 -$0.13-0.79%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -1.64B -959.00M -453.00M -479.00M -560.00M
Total Depreciation and Amortization 1.06B 1.06B 1.08B 1.12B 1.15B
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 2.26B 1.66B 983.00M 967.00M 847.00M
Change in Net Operating Assets -435.00M 102.00M -442.00M -220.00M -72.00M
Cash from Operations 1.25B 1.86B 1.17B 1.39B 1.37B
Capital Expenditure -498.00M -488.00M -489.00M -511.00M -526.00M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -15.00M -15.00M -15.00M -15.00M --
Divestitures 43.00M 39.00M 11.00M 66.00M 68.00M
Other Investing Activities 1.26B 1.36B 1.30B 1.39B 1.43B
Cash from Investing 792.00M 891.00M 807.00M 931.00M 968.00M
Total Debt Issued -- 0.00 700.00M 700.00M 3.15B
Total Debt Repaid -1.64B -1.46B -2.66B -1.70B -4.85B
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -150.00M -237.00M -313.00M -358.00M -212.00M
Cash from Financing -1.79B -1.69B -2.27B -1.36B -1.91B
Foreign Exchange rate Adjustments -174.00M 15.00M -118.00M -146.00M -30.00M
Miscellaneous Cash Flow Adjustments -1.00M 0.00 0.00 -1.00M --
Net Change in Cash 73.00M 1.07B -412.00M 815.00M 393.00M
Weiss Ratings